Two chocolate sexual-enhancement products recalled for undeclared ED drugs

Lockout Supplements issued a voluntary nationwide recall on Feb. 25, 2026, of all lots of Boner Bears Chocolate Syrup after the product was found to contain undeclared sildenafil, prompting the company to remove the item from sale and offer refunds to customers. The Food and Drug Administration included the product in a formal recall notice titled "Lockout Supplements Issues Voluntary Nationwide Recall of Boner Bears Chocolate Syrup Due to Undeclared Sildenafil" and identified the item as Boner Bears Chocolate Syrup UPC 000856683570.

The company, headquartered in McKinney, Texas, said it is notifying customers by website notice and "is arranging for return of all recalled product to include a full refund upon request." The company announcement also said the recalled lots were distributed from Jan. 1, 2025, to Feb. 13, 2026, and Lockout customers with questions can contact the company at 972-548-1988. The FDA's recall notice includes standard consumer guidance: "Consumers that have Boner Bears Chocolate Syrup should stop using/return to place of purchase or discard this product."

Health authorities emphasized risk from the undeclared drug. The FDA warned that "this undeclared ingredient may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels." The recall notice reiterates that "Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product" and states plainly that "FDA does not endorse either the product or the company."

Separately, a seller identified as USALESS.COM is recalling a chocolate-form sexual-enhancement product, Rhino Choco VIP 10X. The sole explicit report on that action states, "USALESS.COM is recalling its Rhino Choco VIP 10X product due to the undeclared presence of Tadalafil, which is the active ingredient in Cialis." That assertion is currently supported by the seller's notification as provided to reporters; public regulatory filings, UPCs, lot numbers, distribution dates, and consumer contact details for the USALESS recall were not available in the materials reviewed and require independent verification.

Together the two actions underscore recurring safety concerns for products marketed for sexual performance. The Lockout recall demonstrates how an apparently innocuous novelty food-form product can carry an undisclosed prescription drug that poses acute risks to people taking nitrate medications or with cardiovascular conditions. The USALESS claim, if confirmed with lab or regulatory documentation, would reflect the same public health problem: undeclared prescription erectile-dysfunction drugs appearing in over-the-counter supplements.

For consumers: stop using the named product, follow the company's return and refund instructions, and consult a health care provider if you have taken the product and experienced symptoms. Those with questions about the Boner Bears recall can call Lockout at the number provided by the company. Reported adverse events related to either product should be submitted to the FDA through its MedWatch system so regulators can track injuries and consider enforcement or further action.

Journalists and public officials seeking to verify the USALESS recall should request company notices, laboratory test results, and any regulatory filings; for Lockout, the FDA recall text contains the primary public record of the action.